Technological survey on LIMS and ELN in Life Sciences - Biogenouest

More documents

Recommendations

Info

4 -‐ Suppliers The introduction of new laboratory activity management methods have been possibleby reproducing the tools designed in-house to meet specific needs: productiondepartment with MES (Manufacturing Execution system), marketing and salesdepartments with CRM (Customer relationship management tools) and the overallresource planning in companies (ERP tools).Even if LIMS/ELN tools are less developed than similar solutions, the market growthremains high. Since 2009, the suppliers’ strategy has changed and is moreestablished as a result of the market entry of major equipment suppliers such asPerkin Elmer, Thermo and Abbott. Activity growth is led by the adoption of thosetools by the main service providers of the Chemical and Pharma industry. Thesecompanies already have feedback on functionalities developed by ELN and LIMSfrom their clients in Life Sciences. Moreover, they have the required internalresources to implement data management solutions (dedicated resources for IT andquality).In SMEs and academic laboratories, the resources dedicated to IT are embryonic.The deployment of ERP in SMEs was done through computer engineering serviceproviders that developed simplified and customized solutions and placed skilledresources not available internally. Since the competitive landscape has beenreconfigured and because there is a high demand for less complex solutions, theLIMS/ELN suppliers will now need to develop a proximity service market according totheir clients’ expectations.5 -‐ Corporate groups Large corporate groups are not currently requesting from their partners (SMEs andacademic laboratories) any specific quality or data management tools because todaythe tools available are designed for large organizations and not for small structures.The data management/ELN are considered as too complex and even disruptive inthe collaboration.However the environment is changing and regulatory bodies are becoming more andmore demanding. SMEs and academic laboratories need to be aware that in the nearfuture, corporate groups will raise their expectations and require data managementtools and quality systems.Therefore, to continue working with corporate groups, Biotechs and academiclaboratories will need to implement data management tools, quality system and alsohire and train skilled resources.6 -‐ Academic laboratories and SMEs The targeted population in the ShareBiotech study (mainly academic laboratoriesand SMEs) was <strong>survey</strong>ed to understand its maturity regarding the ELN and LIMStools. Results showed that there are external and internal incentives to implement adata management solution, however the complexity and the lack of resources do notallow SMEs and academic laboratories to invest in such tools. As a matter of fact,less than 5% of the <strong>survey</strong> respondents have indeed implemented LIMS/ELN.However the activity is slowed down by the complexity to bring new and specific32
customized solutions since they are fundamentally different according to the targetedsegment. As the SME may need to meet an external constraint (a client request forexample), academics are mostly looking for an internal way to protect and organizethe flow of information and data traceability linked to their research.The most frequently expressed downside of ELN and LIMS are the specifications ofthe available tools, still expensive, not adapted and inflexible. The tools available,mainly commercial, is seen by SMEs and academics as complex to set-up and tooexpensive to implement on many workstation. Moreover, the upgrading process tointegrate new functionalities is perceived as complex.Recommendations How will the actors in the field evolve in the upcoming years?The effect of critical mass can certainly be taken over by clusters that have a scopeof activity adapted to collect and share the needs of hundreds of actors. LIMS/ELNsuppliers have also identified clusters as cornerstones for information and solutionimplementation.However, clusters will face the same limitations as academics and SME: lack ofbudget and internal resources.The penetration and implementation of LIMS/ELN in the Life Science market willdepend on the ability of the actors to adapt to a changing environment:- Supplierso Suppliers will need to develop new products more flexible at a lowercost adapted to small structures to meet users needs and enhancepenetration.o They will also need to come up with new business models to fund theinitial customer implementation cost- Clusterso The clusters have been identified by suppliers in the procurementprocess and therefore can be instrumental in the processo Clusters will play a key role in education and training of their members(Lab Managers from technological core facilities and SMEs)o They can also play a key role in connecting with Life ScienceCorporate groups to assess current and future needs for Biotechcompanies and CRO- Academic laboratories & technological core facilityo It is foreseen that IT tools knowledge will become a key competencyin corporate recruitmento Students will need to be properly trained with up-to-date IT tools- Biotech & CROo Adequate tools and market pressure are the key drivers for a widerimplementation of the data management toolso It is essential to foster close contact with Corporate groups to keepabreast of IT evolutionRecommendations from the <strong>survey</strong>ed contacts can be found in Appendix 4.33
Page 1 and 2: Technological <str
Page 3 and 4: ) Implemented quality standards
Page 5 and 6: Survey background 1 -‐ Backg
Page 7 and 8: Computer data management system
Page 9 and 10: The implementation of data manageme
Page 11 and 12: While the vast majority of companie
Page 13 and 14: Figure 7 - LIMS and ELN solutions13
Page 15 and 16: Usage of ELN and LIMS also depends
Page 17 and 18: - Head of platform- Head of resourc
Page 19 and 20: - Need for innovation- Design of ne
Page 21 and 22: ) Implemented quality standards
Page 23 and 24: Nb. of respondents (N=30)3025201510
Page 25 and 26: The perceived benefits of implement
Page 27 and 28: Nb. of respondents (N=17)Surveyed r
Page 29 and 30: As indicated by the suppliers, the
Page 31: 2 -‐ Quality system The <str
Page 35 and 36: Appendix 1: Online surve
Page 37 and 38: □□□□Pas de besoin actuellem
Page 39 and 40: □□□□□Avantage concurrenti
Page 49 and 50: Appendix 3: Surveyed contact li
Page 51 and 52: Appendix 4: Peer recommendations
Page 53: B$: Billion DollarsCRO: Contract Re

Technological survey on LIMS and ELN in Life Sciences - Biogenouest

Create successful ePaper yourself

Delete template?

Save as template?